ALBERTDAVD · Health Care · 2026-08-07

Albert David Ltd

Stage 4 · wk 4In scan: Breakout WatchMARKET: BULL TOPPING · 2026-08-07
₹822.9
+12.63% today
₹470 Cr · Micro cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

Visit company website →
ROE
-0.4%
Profit margin -0.4%
Dividend Yield
0.70%
P/B 1.0
vs 52W High
-8.1%
₹587.1 lo₹895.4 hi
8.1% below 52W high — failed near resistance
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 4
1w13w26w
Week 4 — early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
12.8%
200 DMA: ₹729.7 · sloping down
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
117.44x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
→
MA20 flat · +0.1% vs MA50 -2.0%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
51.6%
20d Δ
+1.6pp
1M return
+3.1%
3M return
+11.6%
Sector Stage-2 % · last 20 days
Sector has 79 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
→ Flat
Stage 2%
50.5%
20d Δ
+0.5pp
1M return
+1.9%
3M return
+11.7%
Industry Stage-2 % · last 20 days
Industry has 53 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-12 → 2026-08-07
S2 45w
S2 22w
S4 22w
S4 20w
2023-05-122026-08-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 3w → S2 45w → S3 9w → S2 22w → S3 11w → S4 22w → S1 9w → S4 10w → S1 4w → S4 20w → S1 11w → S4 3w current
Total tracked: 169 weeks across 12 stage runs.
1M
+18.1%
3M
+3.4%
6M
+20.4%
YTD
+10.5%
1Y
-9.3%
Scan Membership
Breakout Watch
Latest: 2024-06-14
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-07S4
Wk 4 · Vol —x
2026-08-06S4
Wk 4 · Vol —x
2026-08-05S4
Wk 3 · Vol —x
2026-08-04S4
Wk 3 · Vol —x
2026-08-03S4
Wk 3 · Vol —x
2026-07-31S4
Wk 3 · Vol —x
2026-07-30S4
Wk 3 · Vol —x
2026-07-29S4
Wk 2 · Vol —x
2026-07-28S4
Wk 2 · Vol —x
2026-07-27S4
Wk 2 · Vol —x
2026-07-24S4
Wk 2 · Vol —x
2026-07-23S4
Wk 2 · Vol —x
Sector Peers — Stage 2All →
DIVISLAB
wk 12 · -3.6% from hi
8.5
LAURUSLABS
wk 16 · -0.3% from hi
8.4
PPLPHARMA
wk 4 · 0.0% from hi
8.2
LALPATHLAB
wk 9 · 0.0% from hi
7.9
SHILPAMED
wk 13 · 0.0% from hi
7.8
Moving averages & range
50 DMA
₹705.5
200 DMA
₹729.7
52W High
₹895.4
52W Low
₹587.1
5D Low
₹692.6
Resistance levels (recent highs)
20d High
₹822.9
60d High
₹822.9
120d High
₹822.9
250d High
₹883.1
Next resistance
+7.3%
to 250d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.